Received Mar 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | 9pt2f | — |
patient is behind on his vaccines and received his 4th dose of DTaP; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old male patient who received DTPa (Infanrix) (batch number 9pt2f, expiry date 10-MAR-2026) for prophylaxis. On 08-JUL-2025, the patient received the 4th dose of Infanrix. On 08-JUL-2025, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: patient is behind on his vaccines and received his 4th dose of DTaP). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-MAR-2026 The patient was seven years and five months old.